Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

843 studies match

clinicaltrialsPublishedShowing 251–300 of 843 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05633654	Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)	recruiting	Phase 3	1,514	Gilead SciencesINDUSTRY	11	Sep 9, 2026	clinicaltrials
NCT06253871	A Phase 1/1b Study of IAM1363 in HER2 Cancers	recruiting	Phase 1	383	Iambic Therapeutics, IncINDUSTRY	8	Sep 9, 2026